Robin Noël

409 total citations
10 papers, 255 citations indexed

About

Robin Noël is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Robin Noël has authored 10 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Robin Noël's work include CAR-T cell therapy research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Inflammation biomarkers and pathways (2 papers). Robin Noël is often cited by papers focused on CAR-T cell therapy research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Inflammation biomarkers and pathways (2 papers). Robin Noël collaborates with scholars based in France and United States. Robin Noël's co-authors include Jean‐Pierre Quenot, Frédéric Massin, Julien Guy, Sébastien Gibot, Pierre‐Emmanuel Charles, G Fauré, Damien Barraud, Aurélie Cravoisy, Manoel de Carvalho and Marie C. Béné and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and BMC Infectious Diseases.

In The Last Decade

Robin Noël

7 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Noël France 3 187 98 84 41 33 10 255
Anna Linnér Sweden 6 132 0.7× 63 0.6× 78 0.9× 24 0.6× 29 0.9× 7 239
Roman Zazula Czechia 9 187 1.0× 84 0.9× 53 0.6× 40 1.0× 63 1.9× 24 317
R Thomae Germany 3 246 1.3× 60 0.6× 116 1.4× 70 1.7× 67 2.0× 7 304
Sungwoo Moon South Korea 2 155 0.8× 70 0.7× 28 0.3× 42 1.0× 29 0.9× 3 247
Sergey Shlyapnikov Russia 5 173 0.9× 42 0.4× 43 0.5× 79 1.9× 41 1.2× 8 306
Masanao Miura Japan 4 294 1.6× 62 0.6× 167 2.0× 76 1.9× 84 2.5× 13 363
Yasunori Yaegashi Japan 7 239 1.3× 94 1.0× 107 1.3× 67 1.6× 73 2.2× 16 383
Nils‐Olivier Olsson France 9 185 1.0× 53 0.5× 50 0.6× 112 2.7× 43 1.3× 15 327
Sara Cajander Sweden 10 172 0.9× 91 0.9× 25 0.3× 66 1.6× 38 1.2× 26 363
C. Peckelsen Germany 7 190 1.0× 39 0.4× 38 0.5× 93 2.3× 31 0.9× 10 263

Countries citing papers authored by Robin Noël

Since Specialization
Citations

This map shows the geographic impact of Robin Noël's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Noël with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Noël more than expected).

Fields of papers citing papers by Robin Noël

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Noël. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Noël. The network helps show where Robin Noël may publish in the future.

Co-authorship network of co-authors of Robin Noël

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Noël. A scholar is included among the top collaborators of Robin Noël based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Noël. Robin Noël is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Riedell, Peter A., Krish Patel, Yasmin Karimi, et al.. (2024). Plamotamab: First Presentation of Subcutaneous Administration in a Phase 1 Dose Escalation Study in Heavily Pretreated R/R NHL Patients Who Had Prior CAR-T Cell Therapy. Blood. 144(Supplement 1). 4497–4497. 2 indexed citations
3.
Noël, Robin, Christophe Zemmour, Thérèse Aurran‐Schleinitz, et al.. (2023). A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma. Hematology. 28(1). 2207948–2207948.
4.
Fürst, Sabine, Robin Noël, Jean‐Marc Schiano de Colella, et al.. (2022). Allogeneic Transplant As a Curative Option for Relapsed/Refractory Large B-Cell Lymphoma in the Era of CAR T-Cell Therapy: A Monocentric Retrospective Study. Blood. 140(Supplement 1). 7740–7741.
5.
Dubreuil, Julien, et al.. (2017). Isolated hepatosplenic sarcoidosis: A pitfall for lymphoma evaluation by 18 F-FDG PET/CT. Revista Española de Medicina Nuclear e Imagen Molecular. 36(6). 399–400. 2 indexed citations
6.
Charles, Pierre‐Emmanuel, Robin Noël, Frédéric Massin, et al.. (2016). Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis. BMC Infectious Diseases. 16(1). 559–559. 23 indexed citations
7.
Dubreuil, Julien, Robin Noël, Jérémie Tordo, Gilles Salles, & Andrea Skanjeti. (2016). Diffuse Subcutaneous Fat Involvement in a Marginal Zone Lymphoma. Clinical Nuclear Medicine. 42(2). 129–130. 2 indexed citations
8.
Quenot, Jean‐Pierre, et al.. (2014). Mechanisms and etiologies of thrombocytopenia in the intensive care unit: impact of extensive investigations. Annals of Intensive Care. 4(1). 24–24. 12 indexed citations
9.
Quenot, Jean‐Pierre, et al.. (2014). Mechanisms and etiologies of thrombocytopenia in the intensive care unit: impact of extensive investigations. Annals of Intensive Care. 4(1). 24–24. 1 indexed citations
10.
Gibot, Sébastien, Marie C. Béné, Robin Noël, et al.. (2012). Combination Biomarkers to Diagnose Sepsis in the Critically Ill Patient. American Journal of Respiratory and Critical Care Medicine. 186(1). 65–71. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026